INSPIRE VETERINARY PARTNERS, INC.: Delisted from Nasdaq – What Investors Need to Know

A significant event has unfolded for INSPIRE VETERINARY PARTNERS, INC. (IVP) that could impact your investment. The company's stock has been delisted from the Nasdaq Capital Market and now trades on the OTCQB Venture Market. This summary breaks down the key details of this material event in a clear, investor-focused way.

---

1. Event Description: Nasdaq Delisting and Move to OTCQB

INSPIRE VETERINARY PARTNERS, INC. (IVP) stock is no longer listed on the Nasdaq Capital Market. Instead, it now trades on the OTCQB Venture Market under the new symbol "IVPR." This move signifies that IVP no longer meets the listing standards of a major exchange like Nasdaq, transitioning to an over-the-counter market, which typically carries different characteristics and risks.

2. Event Timeline

This delisting followed a specific process:

• November 13, 2025: Nasdaq first notified IVP of its non-compliance with the minimum bid price rule.
• January 13, 2026: The company presented its appeal to a Nasdaq Hearings Panel to avoid delisting.
• January 20, 2026: The Nasdaq Panel denied IVP's request to remain listed.
• January 21, 2026: Nasdaq suspended trading of IVP's stock. On the same day, the stock officially began trading on the OTCQB Venture Market as "IVPR."

3. Why This Happened: Failure to Meet Nasdaq's Minimum Bid Price

IVP's failure to maintain a minimum bid price of $1.00 per share, as required by Nasdaq Listing Rule 5550(a)(2), caused the delisting. The company's stock price remained below this threshold for 30 consecutive business days, which triggered the non-compliance notice and subsequent delisting. While the 8-K filing does not detail the specific reasons for the sustained low stock price, investors should recognize that it often points to broader concerns about a company's financial health, operational challenges, or future growth prospects.

4. Financial Impact

The delisting from Nasdaq and subsequent trading on the OTCQB Venture Market carries several potential financial implications for INSPIRE VETERINARY PARTNERS, INC. and its investors.

• Capital Raising: Trading on the OTCQB market may make it more challenging and potentially more expensive for the company to raise capital through future equity or debt financing. Institutional investors often face restrictions on investing in non-exchange-listed securities.
• Liquidity and Valuation: The 8-K does not provide specific financial projections. However, the OTCQB market typically experiences lower trading volumes and fewer market makers compared to Nasdaq. This reduced liquidity, combined with the generally negative perception of a delisting, could pressure the company's valuation and the market price of its common stock downward.
• Operational Continuity: The company has stated its intention to continue its business operations. The 8-K filing does not disclose any immediate direct financial impact on the company's day-to-day operations or its ability to meet existing financial obligations.
• Reporting Obligations: The company intends to continue filing periodic and current reports with the Securities and Exchange Commission (SEC). This includes annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, which will continue to provide financial transparency to investors.

5. Impact Assessment: Critical Implications for IVP and Investors

This delisting represents a material event with several significant consequences:

• Reduced Visibility and Credibility: Nasdaq listing offers greater prestige, analyst coverage, and institutional investor interest. Moving to the OTCQB can significantly reduce IVP's public profile and perceived credibility.
• Liquidity Concerns for Investors: While the financial impact on the company's valuation is noted, the OTCQB market typically has lower trading volumes and fewer market makers compared to Nasdaq. This can lead to:
  • Wider Bid-Ask Spreads: The difference between the price you can sell at and the price you can buy at may increase, making trades less efficient.
  • Difficulty Executing Trades: Investors might find it harder to buy or sell shares quickly at their desired price without significantly impacting the stock price.
  • Fewer Buyers and Sellers: Overall market participation may decrease, further impacting liquidity for individual investors.
• Increased Risk Perception: The market generally views delisting negatively, signaling increased risk. This can further depress the stock price and investor confidence.
• Brokerage Access: Some brokerage firms may have restrictions or higher fees for trading OTCQB-listed securities. Investors should confirm their broker's policies.

6. Key Takeaways for Investors: What the Filing Doesn't Detail

The 8-K filing primarily focuses on the procedural aspects of the delisting. Critical information for investors that this filing does not detail includes:

• Financial Health Beyond Stock Price: The 8-K does not provide specific financial metrics (e.g., revenue trends, profitability, cash flow, debt levels) that contributed to the low stock price. Investors should review IVP's latest quarterly and annual reports (10-Q and 10-K filings) for a deeper understanding of the company's financial standing.
• Strategic Plan to Address Underlying Issues: The filing does not outline any concrete strategies or initiatives IVP plans to implement to improve its financial performance, regain investor confidence, or potentially return to a major exchange in the future.
• Impact on Operations and Growth: The filing lacks discussion on how the delisting might affect IVP's day-to-day operations, its ability to attract and retain talent, or its growth strategies within the veterinary services market.
• Specific Measures to Enhance Shareholder Value: Beyond continuing SEC filings, the company has not articulated specific steps it will take to mitigate the negative impacts of delisting and enhance shareholder value.

7. Key Takeaways for Investors: What Happens Next and What You Should Do

• Continued SEC Filings: IVP has stated its intention to continue filing periodic and current reports with the SEC (10-K, 10-Q, 8-K). These filings will serve as the primary source of official financial and operational information.
• Formal Delisting: Nasdaq will formally file a Form 25 with the SEC to complete the removal of IVP's securities from its exchange.
• Monitor Company Communications: Investors should closely follow future press releases and SEC filings from IVP for any updates on its financial performance, strategic plans, and efforts to address the challenges highlighted by the delisting.
• Assess Your Investment: Given the increased risks and reduced liquidity, investors should re-evaluate their position in IVP, considering their personal risk tolerance and investment objectives. Understand that the OTCQB market can be more volatile and less transparent.

This delisting marks a significant shift for IVP. While the company will continue to provide public financial information, the move to the OTCQB market fundamentally changes the investment landscape for its shares. Investors should proceed with caution and conduct thorough due diligence.